MHRA

The number of reports from community pharmacists to the yellow card reporting system fell between 2018 and 2017.

M&A Pharmachem has recalled batches of paracetamol 500mg tablets because of “a small number" of contaminated pots.

With 100 days to go before the February 9 deadline for the Falsified Medicines Directive, community pharmacies should not delay in ensuring they are FMD-ready, the National Pharmacy Association has said

The consultation deals with how legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s exit, with no implementation period

Products containing doses equal to or greater than 1178mg/day of base glucosamine will now be considered to be medicines, the MHRA has announced

The European Medicines Agency has issued an update on its investigation into the health risks of taking valsartan medicines containing an impurity that may have carcinogenic potential

Arrangements for medicines supply following Brexit may not be clear until “the 11th hour”

The MHRA claims that trading in diazepam 10mg has fallen as a result of its efforts to stop the illegal diversion of medicines to the black market

It's important to reassure people that head lice treatments are appropriately safe when used correctly, PAGB said in its response

In an undercover investigation carried out by Which?, three in 10 pharmacies did not follow safety guidelines when making sales of OTC pain medicines

Criminal gangs are diverting hundreds of millions of pounds worth of prescription drugs into the black market, according to a recent File on 4 report

With the MHRA’s approval of a POM to P switch for sildenafil, UK men will be able to access an ED medicine over the counter for the first time

Boots UK has announced it is to launch an online erectile dysfunction service, which the retailer says will be its biggest online pharmacy service to date

The Royal Pharmaceutical society has welcomed the MHRA's decision to reclassify Dovonex Psoriasis Ointment as a Pharmacy medicine

MHRA has announced the reclassfication of the allergic rhinitis medicine, shortly after the Maloff Protect POM to P switch was confirmed

MHRA has announced the reclassification of antimalarial Maloff Protect from prescription only to a Pharmacy medicine

The UK FMD Working Group for Community Pharmacy says the process, which comes into effect in 2019, should have minimal impact on pharmacy working practices

A novel online advent calendar reveals a fact about counterfeit medicines each day until Christmas